![\"\"](\"https:\/\/i1.wp.com\/principia-scientific.com\/wp-content\/uploads\/2021\/01\/fhfh.jpg?resize=550%2C383&ssl=1\")
<\/p>\nWritten by Patrick Delaney
\nLifeSite News<\/p>\n
<\/p>\n
While the United States continues its aggressive\u00a0military<\/a>\u00a0roll-out of\u00a0novel<\/a>, expensive and\u00a0dangerous<\/a>\u00a0pharmaceutical vaccines, India has developed a \u201cmiraculously\u201d effective and safe COVID-19 treatment kit which costs merely $2.65 per person and has helped put the nation\u2019s case and fatality rates in \u201csteep decline.\u201d<\/p>\n <\/span>Last month, several medical experts\u00a0testified<\/a>\u00a0before the U.S. Senate Homeland Security Committee in favor of authorizing ivermectin for early treatment of the novel coronavirus. Among them, Dr. Pierre Kory,\u00a0founding member of\u00a0Front Line Covid-19 Critical Care Alliance<\/a>\u00a0(FLCCC),\u00a0explained<\/a>\u00a0that ivermectin, a Nobel Prize\u2013winning anti-parasitic agent, \u201cbasically obliterates transmission of this virus,\u201d with \u201cmiraculous effectiveness.\u201d<\/p>\n Ivermectin has been the subject of\u00a0dozens of studies<\/a>\u00a0and anecdotal success stories since it was\u00a0found<\/a>\u00a0to reduce COVID-19 in a laboratory last June.<\/p>\n \u201cI\u2019ve been treating COVID pretty much every single day since the onset,\u201d Kory said. \u201cWhen I say \u2018miracle\u2019 I do not use that term lightly\u2026that is a scientific recommendation based on mountains of data that has emerged in the last three months.\u201d<\/p>\n FLCCC has developed a\u00a0treatment regimen<\/a> incorporating ivermectin, which the group claims has led to up to 83% lower-than-average COVID-19 death rates in hospitals that have applied it.<\/p>\n However, the Food and Drug Administration (FDA) has\u00a0refused emergency authorization<\/a>\u00a0of ivermectin to treat coronavirus, stating for months that \u201c[m]ore testing is needed.\u201d<\/p>\n In contrast, on the other side of the world, India has embraced the treatment protocol specified by Dr. Kory and his colleagues and is now manufacturing this product under the brand name \u201cZiverdo Kit\u201d and it only costs approximately $2.65 per person.<\/p>\n While the World is on a vaccine frenzy, the Indian Government is distributing a home Covid Kit with Zinc, Doxycycline and Ivermectin. The cost $2.65 per person.\u00a0pic.twitter.com\/CphhwO8pXE<\/a><\/p>\n \u2014 Sam Bardo (@SamBardo1)\u00a0December 16, 2020<\/a><\/p><\/blockquote>\n Though the U.S. National Institutes of Health (NIH)\u00a0recommends<\/a>\u00a0no treatment<\/a>\u00a0for those suffering from SARS-COV-2 \u201cunless the patient is hospitalized and requires oxygen,\u201d in India, they began treating coronavirus patients early, including the use of hydroxychloroquine (HCQ).<\/p>\n Dr. Makarand Paranjpe and his wife, both 77 year-old Indian physicians, fully recovered from the COVID-19 virus using early treatment last November,\u00a0TrialSiteNews<\/a>\u00a0(TSN) reports. She used hydroxychloroquine, and he took ivermectin.<\/p>\n \u201cWithout any treatment, we know that the virus enters the cells and replicates there,\u201d Paranjpe said. \u201cThey can create disease that gets much more severe.\u201d Stopping such replication as early as possible is the simple function of these inexpensive and safe treatments.<\/p>\n Last March, as debates raged in the U.S. over the merits of HCQ, following President Trump\u2019s endorsement of the drug, India had already\u00a0recommended<\/a>\u00a0it in its national guidelines affirming it \u201cshould be used as early in the disease course as possible\u2026and should be avoided in patients with severe disease.\u201d<\/p>\n Following the June discovery of ivermectin\u2019s efficacy in treating the virus, along with significant subsequent testing, the largest state in their nation, Uttar Pradesh (UP) (pop. 230 million),\u00a0announced<\/a>\u00a0in August that it was replacing their HCQ protocol with ivermectin for the prevention and treatment of COVID-19.<\/p>\n \u201cBy the end of 2020, Uttar Pradesh \u2014 which distributed free ivermectin for home care \u2014 had the second-lowest fatality rate in India at 0.26 per 100,000 residents in December.\u00a0Only the state of Bihar, with 128 million residents, was lower, and it, too,\u00a0recommends ivermectin<\/a>,\u201d writes Mary Beth Pfeiffer of TSN.<\/p>\n By further comparison, utilizing early treatment with HCQ and ivermectin, the densely populated India, which has four times the population of the U.S., has less than half of the coronavirus related deaths. \u201cAnd India isn\u2019t just beating the poorly performing U.S. In all, 98 nations have\u00a0higher death rates<\/a>\u00a0than India,\u201d Pfeiffer writes.<\/p>\n Dr. Anil K. Chaurasia, a physician in UP, affirmed that starting in mid-September, \u201ca clear decline in COVID cases and fatalities in India was noticeable \u2026 [and the] \u201csteep decline in cases and fatalities is still continuing.\u201d<\/p>\n The same results hold for neighboring Bangladesh, one of the most densely populated nations in the world, where doctors also utilize an ivermectin home care therapy, and they have an even lower fatality rate,\u00a0ranking<\/a>\u00a0128th<\/sup>in the world.<\/p>\n Kory cited similar results in Peru, Argentina, Brazil and several other South American countries demonstrating the effectiveness of ivermectin.<\/p>\n For example, in his written testimony to the senate committee, he\u00a0related<\/a>\u00a0that in Peru, \u201cthe peak in deaths occurred at the time of distribution\u201d of ivermectin, which the country approved for COVID-19 treatment in late spring. Every Peruvian state witnessed \u201crapid and sustained reduction in both case counts and death rates in patients\u201d as ivermectin circulated, he wrote.<\/p>\n In the face of such new and broad evidence, however, the FDA and NIH have nonetheless remained unwavering in their rejection of ivermectin as a tool to combat coronavirus, and instead have maintained a central focus on vaccines.<\/p>\n And while HCQ and ivermectin have been around for many decades, and are known to be quite safe, serious concerns remain regarding these COVID-19 vaccines which have been\u00a0rushed<\/a>\u00a0through the process of development, testing, approval, and now distribution, with a new \u201cmessenger RNA<\/a>\u201d technology,\u00a0no industry-standard animal trials<\/a>, nor any sufficient studies on long-term effects.<\/p>\n These concerns\u00a0include<\/a>\u00a0\u201callergic\u201d and \u201cpotentially fatal reactions,\u201d as well as concerns about the potential impact on\u00a0fertility<\/a>.<\/p>\n The FDA even drew up a\u00a0document<\/a>\u00a0this fall listing the possible side-effects from a COVID-19 vaccine, including strokes, encephalitis, auto-immune disease, birth defects, Kawasaki disease, and death.<\/p>\n Present reports reveal that\u00a0hundreds<\/a>\u00a0of individuals injected with these vaccines have been\u00a0admitted<\/a>\u00a0to the hospital, and at least two\u00a0have<\/a>\u00a0died<\/a>.<\/p>\n Though these U.S. regulatory agencies maintain \u201c[m]ore testing is needed,\u201d before approving ivermectin, Pfeiffer observes, \u201c[m]ore information is always better. But at what point, in a pandemic, is there enough?\u201d<\/p>\n Kory forcefully asserted to the senate, \u201cthe amount of evidence that I have presented far exceed[s] the level required for a compassionate use authorization as defined by the FDA.\u201d<\/p>\n Ivermectin \u201cneeds to be immediately adopted systematically nationally and globally, period,\u201d he insisted.<\/p>\n \u201cYou can use this medication in just about any condition,\u201d he said. \u201cIt is safe, inexpensive, [and] widely available.\u201d<\/p>\n Read more here:\u00a0www.lifesitenews.com<\/a><\/p>\n\n